websites were collected using a Java-based natural language processing platform. Two hundred randomized posts were analyzed using grounded theory methodology. The focus group and digital ethnography data sets were coded independently and then compared.
INTRODUCTION AND OBJECTIVES: Prescription Drug Monitoring Programs (PDMPs) have been introduced nationwide as a tool to combat opioid overprescribing. Since 2017, urologists in Pennsylvania must query the PDMP by law prior to any prescriptions for postoperative opioids. We aim to assess if a required PDMP query reduced opioid prescriptions in a postoperative urologic oncology population at our institution.
METHODS: The PDMP query requirement was initiated on January 1st, 2017. After this date, providers were required to search the database prior to prescribing opioids. With institutional review board approval, we identified patients who either underwent a prostatectomy or nephrectomy from July 1st, 2016 to June 30th, 2017 to obtain 6 months of data before and after query requirement. Patient demographics, pre-op opioid use, and opioid prescribing habits were obtained from the electronic medical record. Prescriptions were converted into a 5mg oxycodone-equivalent Prescribing habits were dichotomized to pre-and post-PDMP query and analyzed using Chisquare and Mann-Whitney U tests with SPSS (Version 25).
RESULTS: We identified 582 patients (293 prior to required PDMP query and 289 post-PDMP query). There were no differences in sex (p[ 0.44), preoperative opioid use (p[0.62), case type (p[0.74), or age (p[0.99). There were significantly more median pills prescribed before (33) than after (27) the required PDMP query (p<0.001) (Figure) .
CONCLUSIONS: The introduction of a required PDMP query was associated with an immediate 30% decrease from December 2016 to January 2017 in opioids prescribed at our institution. A required PDMP query is an effective tool in reducing overprescribing of postoperative opioids in a population of urology patients. 
INTRODUCTION AND OBJECTIVES:
The opioid epidemic is a public health threat in the United States. Although there have been numerous studies to suggest the deleterious long term effect of overprescribing opioids in the acute postoperative period, no series have rigorously assessed prescribing patterns in urologic surgery patients following discharge. Here, we assess prescribing and refilling trends of opioid narcotics in those undergoing urologic surgery at our institution METHODS: We reviewed all urologic operative cases at our academic medical center from May 2017-April 2018. Demographic data, comorbidities, and perioperative pain management strategies were recorded and analyzed. All narcotics utilized following surgery were tabulated and reported in total morphine equivalents (TME, mg). Upon discharge from the hospital, patients were instructed to contact the Urology office for any postoperative issue following discharge, including persistent postoperative pain. A mandatory statewide narcotics utilization registry was queried for each patient to assess postoperative narcotics prescriptions along with refill data. Logistic regression analyses assessed independent predictors of those at risk of obtaining a narcotic refill following urologic surgery.
RESULTS: Of 820 cases (median age 59, median discharge TME 30mg), 30.1% (median age 56, IQR 45-66) of the cohort required a narcotic refill following discharge (median TME 32 mg, IQR 20-59 mg). Urologists (U) were responsible for 47% of refills while primary care Vol. 201, No. 4S, Supplement, Saturday, May 4, 2019 THE JOURNAL OF UROLOGY Ò e453
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